Steven M. Haffner

Steven M. Haffner's AcademicInfluence.com Rankings

Steven M. Haffner

Philosophy

#2354

World Rank

#4051

Historical Rank

Logic

#540

World Rank

#983

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Steven M. Haffner's Degrees

Bachelors Biology University of California, Berkeley
PhD Biomedical Sciences Harvard University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is Steven M. Haffner Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Steven M. Haffner's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) (10068)
Global Prevalence and Major Risk Factors of Diabetic Retinopathy (2012) (3473)
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. (1998) (3318)
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. (2006) (2910)
Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). (2000) (2504)
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. (2006) (2183)
Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study (2003) (1584)
NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. (2003) (1506)
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes (2007) (1502)
Cardiorenal end points in a trial of aliskiren for type 2 diabetes. (2012) (1133)
Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. (2002) (1131)
The prevalence of diabetic retinopathy among adults in the United States. (2004) (1114)
Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? (1990) (1076)
The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial (2005) (968)
Prospective Analysis of The Insulin-Resistance Syndrome (Syndrome X) (1992) (906)
Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus (2002) (896)
The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. (2003) (863)
The Homeostasis Model in the San Antonio Heart Study (1997) (795)
Management of Dyslipidemia in Adults With Diabetes (1998) (792)
Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? (2004) (761)
International Day for the Evaluation of Abdominal Obesity (IDEA): A Study of Waist Circumference, Cardiovascular Disease, and Diabetes Mellitus in 168 000 Primary Care Patients in 63 Countries (2007) (749)
Impact of Diabetes on Mortality After the First Myocardial Infarction (1998) (720)
Insulin Sensitivity and Atherosclerosis (1996) (714)
The relation of body fat mass and distribution to markers of chronic inflammation (2001) (713)
National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study (2004) (690)
Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. (2003) (683)
Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial. (2006) (681)
Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. (1998) (676)
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome (1991) (650)
Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. (2002) (629)
Effect of valsartan on the incidence of diabetes and cardiovascular events. (2010) (626)
The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. (1999) (625)
Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. (2002) (604)
A Prospective Analysis of the HOMA Model: The Mexico City Diabetes Study (1996) (593)
The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. (2006) (575)
Prospective analysis of the insulin-resistance syndrome (syndrome X). (1992) (569)
Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. (2005) (566)
Increased Insulin Resistance and Insulin Secretion in Nondiabetic African-Americans and Hispanics Compared With Non-Hispanic Whites: The Insulin Resistance Atherosclerosis Study (1996) (545)
Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. (2002) (534)
Rosiglitazone-Associated Fractures in Type 2 Diabetes (2008) (509)
Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test? (2002) (508)
Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans--a 7-year prospective study. (1997) (505)
The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results. (1995) (500)
Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. (2003) (500)
Effects of Diabetes and Level of Glycemia on All-Cause and Cardiovascular Mortality: The San Antonio Heart Study (1998) (497)
Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention Program (2007) (497)
Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. (2002) (485)
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel (2006) (478)
Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study. (1999) (471)
Incidence of Type II Diabetes in Mexican Americans Predicted by Fasting Insulin and Glucose Levels, Obesity, and Body-Fat Distribution (1990) (466)
Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. (2000) (466)
Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. (2005) (443)
Effect of nateglinide on the incidence of diabetes and cardiovascular events. (2010) (440)
Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. (2005) (425)
Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes (2006) (409)
Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. (2004) (396)
Dyslipidemia management in adults with diabetes. (2004) (391)
Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. (1998) (384)
Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. (2000) (383)
Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study (2006) (383)
Development of the multiple metabolic syndrome: an epidemiologic perspective. (1998) (380)
Effects of acculturation and socioeconomic status on obesity and diabetes in Mexican Americans. The San Antonio Heart Study. (1988) (360)
Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans. The San Antonio Heart Study. (1984) (356)
Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus. (1986) (353)
Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. (2005) (349)
The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group. (2000) (349)
Epidemic obesity and the metabolic syndrome. (2003) (348)
Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. (1986) (341)
Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. (1995) (330)
Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study. (2004) (329)
Changes in Insulin Sensitivity and Insulin Release in Relation to Glycemia and Glucose Tolerance in 6,414 Finnish Men (2009) (328)
Insulin Resistance, Body Fat Distribution, and Sex Hormones in Men (1994) (320)
Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. (1996) (319)
Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship With Cardiometabolic Risk/Intra-Abdominal Adiposity. (2012) (317)
Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. (2003) (317)
Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design. (2009) (311)
Decreased Insulin Secretion and Increased Insulin Resistance Are Independently Related to the 7-Year Risk of NIDDM in Mexican-Americans (1995) (310)
Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. (2005) (307)
Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. (1999) (306)
Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. (1999) (299)
Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. (1988) (296)
Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? (1990) (289)
Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. (1996) (287)
Insulin resistance, inflammation, and the prediabetic state. (2003) (283)
Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians. (2003) (282)
The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. (2006) (280)
Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). (1999) (277)
Coronary heart disease in patients with diabetes. (2000) (273)
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. (2005) (271)
Prediction of Type 2 Diabetes Mellitus With Alternative Definitions of the Metabolic Syndrome: The Insulin Resistance Atherosclerosis Study (2005) (270)
Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. (1996) (266)
Insulin resistance implications for type II diabetes mellitus and coronary heart disease. (1997) (251)
A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes. (2002) (249)
Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. (2008) (249)
Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study. (2002) (241)
Relationship of sex hormones to lipids and lipoproteins in nondiabetic men. (1993) (238)
Epidemiology of Type 2 Diabetes: Risk Factors (1998) (238)
Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men. (1994) (235)
Increased insulin concentrations in nondiabetic offspring of diabetic parents. (1988) (232)
Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS). (1997) (228)
Adherence to the DASH Diet Is Inversely Associated With Incidence of Type 2 Diabetes: The Insulin Resistance Atherosclerosis Study (2009) (226)
Inflammation in the Prediabetic State Is Related to Increased Insulin Resistance Rather Than Decreased Insulin Secretion (2003) (220)
Obesity, body fat distribution and sex hormones in men. (1993) (220)
Diabetic Retinopathy in Mexican Americans and Non-Hispanic Whites (1988) (220)
Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. (2004) (215)
Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. (2003) (214)
Nuclear Magnetic Resonance Lipoprotein Abnormalities in Prediabetic Subjects in the Insulin Resistance Atherosclerosis Study (2005) (214)
Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance Atherosclerosis Study (IRAS) (1997) (212)
The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. (2003) (212)
Genetic and Environmental Determinants of Type II Diabetes in Mexico City and San Antonio (1992) (211)
A comparison of three indicators for identifying Mexican Americans in epidemiologic research. Methodological findings from the San Antonio Heart Study. (1986) (211)
Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. (1992) (210)
The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. (1992) (210)
Genetic analysis of the IRS. Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures. (1996) (206)
Microalbuminuria Precedes the Development of NIDDM (1994) (206)
Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. (2014) (205)
Excess incidence of treatment of end-stage renal disease in Mexican Americans. (1988) (205)
Sleep duration as a risk factor for incident type 2 diabetes in a multiethnic cohort. (2009) (204)
Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites. San Antonio Heart Study. (1990) (202)
Effects of Rosiglitazone, Glyburide, and Metformin on β-Cell Function and Insulin Sensitivity in ADOPT (2011) (202)
Increased Incidence of Type II Diabetes Mellitus in Mexican Americans (1991) (201)
Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. (2002) (199)
The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease. (1998) (199)
Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol. (1984) (198)
Sex steroid hormones, upper body obesity, and insulin resistance. (2002) (192)
Relationship of Metabolic Risk Factors and Development of Cardiovascular Disease and Diabetes (2006) (191)
Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals (2011) (189)
Report of the American Diabetes Association's Task Force on Standardization of the Insulin Assay (1996) (187)
Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis (2014) (187)
Obesity Is a Major Determinant of the Association of C-Reactive Protein Levels and the Metabolic Syndrome in Type 2 Diabetes (2006) (187)
Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline. (2008) (185)
Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in men. (1993) (183)
Leptin Concentrations in Diabetic and Nondiabetic Mexican-Americans (1996) (182)
Epidemiology of insulin resistance and its relation to coronary artery disease. (1999) (180)
Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. (2004) (179)
Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. (2005) (178)
Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. (2009) (177)
Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe. (2004) (177)
Diabetes and Progression of Carotid Atherosclerosis: The Insulin Resistance Atherosclerosis Study (2003) (177)
Upper body and centralized adiposity in Mexican Americans and non-Hispanic whites: relationship to body mass index and other behavioral and demographic variables. (1986) (176)
Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. (2000) (174)
Insulin Sensitivity and Abdominal Obesity in African-American, Hispanic, and Non-Hispanic White Men and Women: The Insulin Resistance and Atherosclerosis Study (1996) (174)
Updated Genetic Score Based on 34 Confirmed Type 2 Diabetes Loci Is Associated With Diabetes Incidence and Regression to Normoglycemia in the Diabetes Prevention Program (2011) (173)
Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes. (2010) (172)
Abdominal adiposity and cardiometabolic risk: do we have all the answers? (2007) (170)
Risk of noninsulin dependent diabetes mellitus conferred by obesity and central adiposity in different ethnic groups: a comparative analysis between Asian Indians, Mexican Americans and Whites. (1997) (170)
Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women. (1995) (166)
Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. (2007) (165)
Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. (2003) (161)
Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and clinical correlation (2000) (161)
Mode of onset of type 2 diabetes from normal or impaired glucose tolerance. (2004) (160)
A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors (2010) (160)
All-cause and cardiovascular mortality among Mexican-American and non-Hispanic White older participants in the San Antonio Heart Study- evidence against the "Hispanic paradox". (2003) (160)
Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study. (1998) (159)
Promoter (4G/5G) Plasminogen Activator Inhibitor-1 Genotype and Plasminogen Activator Inhibitor-1 Levels in Blacks, Hispanics, and Non-Hispanic Whites: The Insulin Resistance Atherosclerosis Study (2003) (158)
Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass (2002) (156)
Essential Hypertension: An Insulin‐Resistant State (1990) (155)
The prevention of type 2 diabetes (2008) (155)
The relationship of sex hormones to hyperinsulinemia and hyperglycemia. (1988) (154)
Hypertriglyceridemic Waist Phenotype Predicts Increased Visceral Fat in Subjects With Type 2 Diabetes (2009) (154)
Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy. (1983) (152)
The Metabolic Profile of NIDDM Is Fully Established in Glucose-Tolerant Offspring of Two Mexican-American NIDDM Parents (1992) (152)
Duration of diabetes and carotid wall thickness. The Insulin Resistance Atherosclerosis Study (IRAS). (1997) (149)
Obesity, Adipokines, and Prostate Cancer in a Prospective Population-Based Study (2006) (148)
Ethnic differences in carotid wall thickness. The Insulin Resistance Atherosclerosis Study. (1996) (147)
Progression of Plasminogen Activator Inhibitor-1 and Fibrinogen Levels in Relation to Incident Type 2 Diabetes (2006) (147)
Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA study). (2015) (144)
A Single Factor Underlies the Metabolic Syndrome: A Confirmatory Factor Analysis (2006) (144)
Comparison of the Associations of Apolipoprotein B and Non–High-Density Lipoprotein Cholesterol With Other Cardiovascular Risk Factors in Patients With the Metabolic Syndrome in the Insulin Resistance Atherosclerosis Study (2004) (143)
Relationship of prevalence of non‐insulin‐dependent diabetes mellitus to Amerindian admixture in the Mexican Americans of San Antonio, Texas (1986) (142)
Metabolic precursors of hypertension. The San Antonio Heart Study. (1996) (140)
Incidence of Type 2 Diabetes in the Randomized Multiple Risk Factor Intervention Trial (2005) (140)
Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study. (2004) (139)
Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal women. (1991) (138)
Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans. (2007) (138)
Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome. (2003) (137)
Comparison of the Associations of Apolipoprotein B and Low-Density Lipoprotein Cholesterol With Other Cardiovascular Risk Factors in the Insulin Resistance Atherosclerosis Study (IRAS) (2003) (137)
Insulin Resistance and Hypertension: The Insulin Resistance Atherosclerosis Study (2004) (137)
Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study. (2012) (135)
Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators. (1997) (134)
The Insulin Resistance Atherosclerosis Study Family Study (2004) (133)
Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. (1996) (132)
Pre-diabetes, insulin resistance, inflammation and CVD risk. (2003) (130)
Relationship of Abdominal Visceral and Subcutaneous Adipose Tissue With Lipoprotein Particle Number and Size in Type 2 Diabetes (2008) (128)
Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. (2004) (128)
Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes (2010) (125)
Myocardial infarction in Mexican-Americans and non-Hispanic whites. The San Antonio Heart Study. (1991) (124)
LDL size and risk of coronary heart disease in elderly men and women. (1999) (124)
Association of Upper Trunk and Visceral Adipose Tissue Volume With Insulin Resistance in Control and HIV-Infected Subjects in the FRAM Study (2007) (123)
Leptin concentrations in relation to overall adiposity and regional body fat distribution in Mexican Americans. (1996) (123)
Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis. (1982) (123)
Cholesterol-lowering benefits of oat-containing cereal in Hispanic americans. (2005) (123)
Carotid artery intima-media thickness in elderly patients with NIDDM and in nondiabetic subjects. (1996) (121)
A population perspective on diabetes prevention: whom should we target for preventing weight gain? (2003) (121)
Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test. (2008) (120)
Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial). (2009) (119)
Increased High-Density Lipoprotein Cholesterol Predicts the Pioglitazone-Mediated Reduction of Carotid Intima-Media Thickness Progression in Patients With Type 2 Diabetes Mellitus (2008) (119)
Leptin concentrations, sex hormones, and cortisol in nondiabetic men. (1997) (118)
Quantitative Trait Analysis of Type 2 Diabetes Susceptibility Loci Identified From Whole Genome Association Studies in the Insulin Resistance Atherosclerosis Family Study (2008) (118)
Whole and refined grain intakes are related to inflammatory protein concentrations in human plasma. (2010) (117)
Effects of cigarette smoking, diabetes, high cholesterol, and hypertension on all-cause mortality and cardiovascular disease mortality in Mexican Americans. The San Antonio Heart Study. (1996) (116)
Serum pentadecanoic acid (15:0), a short-term marker of dairy food intake, is inversely associated with incident type 2 diabetes and its underlying disorders. (2014) (116)
Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study. (2006) (116)
Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women. (1992) (115)
All-cause and cardiovascular mortality among diabetic participants in the San Antonio Heart Study: evidence against the "Hispanic Paradox". (2002) (115)
Sleep duration and five-year abdominal fat accumulation in a minority cohort: the IRAS family study. (2010) (115)
Body Size and Shape Changes and the Risk of Diabetes in the Diabetes Prevention Program (2007) (115)
Relationship of Proinsulin and Insulin to Cardiovascular Risk Factors in Nondiabetic Subjects (1993) (115)
Correlates and Heritability of Nonalcoholic Fatty Liver Disease in a Minority Cohort (2009) (115)
Disposition Index, Glucose Effectiveness, and Conversion to Type 2 Diabetes (2010) (114)
Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey. (1989) (114)
Minimal model-based insulin sensitivity has greater heritability and a different genetic basis than homeostasis model assessment or fasting insulin. (2003) (113)
Association of dietary and life-style factors with sex hormones in postmenopausal women. (1995) (113)
Proteinuria in Mexican Americans and Non-Hispanic Whites With NIDDM (1989) (113)
AMERICAN DIABETES ASSOCIATION. DYSLIPIDEMIA MANAGEMENT IN ADULTS WITH DIABETES (2004) (112)
The role of behavioral variables and fat patterning in explaining ethnic differences in serum lipids and lipoproteins. (1986) (111)
Branched-Chain Amino Acids and Insulin Metabolism: The Insulin Resistance Atherosclerosis Study (IRAS) (2016) (110)
Leptin concentrations and insulin sensitivity in normoglycemic men (1997) (108)
Sex hormone-binding protein, hyperinsulinemia, insulin resistance and noninsulin-dependent diabetes. (1996) (108)
Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study (2009) (107)
The association of obesity and glucose and insulin concentrations with bone density in premenopausal and postmenopausal women. (1993) (107)
The dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein2 cholesterol. (1987) (107)
LDL size in African Americans, Hispanics, and non-Hispanic whites : the insulin resistance atherosclerosis study. (1999) (107)
Greater Effect of Diabetes on LDL size in Women Than in Men (1994) (107)
Analysis of FTO gene variants with measures of obesity and glucose homeostasis in the IRAS Family Study (2009) (106)
Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans. (1990) (106)
Relation of Abdominal Fat Depots to Systemic Markers of Inflammation in Type 2 Diabetes (2009) (106)
Retinopathy Predicts Coronary Heart Disease Events in NIDDM Patients (1996) (103)
Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects. (2006) (103)
Relation of sex hormones and dehydroepiandrosterone sulfate (DHEA-SO4) to cardiovascular risk factors in postmenopausal women. (1995) (103)
Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atherosclerosis Study). (2000) (102)
Treatment of cardiovascular and renal risk factors in the diabetic hypertensive. (2002) (102)
Circulating levels of TNF-α are associated with impaired glucose tolerance, increased insulin resistance, and ethnicity: the Insulin Resistance Atherosclerosis Study. (2012) (101)
Migration status, socioeconomic status, and mortality rates in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study. (1996) (100)
Effect of Socioeconomic Status on Hyperglycemia and Retinopathy Levels in Mexican Americans With NIDDM (1989) (99)
Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects. (2000) (99)
The Relation of Proinsulin, Insulin, and Proinsulin-to-Insulin Ratio to Insulin Sensitivity and Acute Insulin Response in Normoglycemic Subjects (1997) (98)
Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men (1997) (96)
Proinsulin and Specific Insulin Concentration in High- and Low-Risk Populations for NIDDM (1994) (96)
Predictors of weight change in a bi-ethnic population. The San Antonio Heart Study. (1994) (96)
Parental history of diabetes is associated with increased cardiovascular risk factors. (1989) (96)
Endogenous sex hormones: impact on lipids, lipoproteins, and insulin. (1995) (95)
Central adiposity determines prevalence differences of the metabolic syndrome. (2003) (95)
Alanine Aminotransferase and Directly Measured Insulin Sensitivity in a Multiethnic Cohort (2007) (95)
Serum leptin levels in Mexican Americans and non-Hispanic whites: association with body mass index and cigarette smoking. (1997) (94)
Diabetes, hyperlipidemia, and coronary artery disease. (1999) (94)
A 1-Year Lifestyle Intervention for Weight Loss in Individuals With Type 2 Diabetes Reduces High C-Reactive Protein Levels and Identifies Metabolic Predictors of Change (2010) (94)
Lack of association between lipoprotein (a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. (1992) (93)
Relation of direct and surrogate measures of insulin resistance to cardiovascular risk factors in nondiabetic finnish offspring of type 2 diabetic individuals. (2010) (93)
Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the "minimal model". Insulin Resistance Atherosclerosis Study (IRAS) Investigators. (1998) (93)
Physical activity in individuals at risk for diabetes: Diabetes Prevention Program. (2006) (93)
Plasma Oxidizability in Subjects With Normal Glucose Tolerance, Impaired Glucose Tolerance, and NIDDM (1995) (93)
Dietary intakes of macronutrients among Mexican Americans and Anglo Americans: the San Antonio heart study. (1985) (93)
Effect of Progression From Impaired Glucose Tolerance to Diabetes on Cardiovascular Risk Factors and Its Amelioration by Lifestyle and Metformin Intervention (2009) (92)
Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome. (1994) (92)
Change in Body Size and the Risk of Colorectal Adenomas (2007) (92)
Type II diabetes and its complications in Mexican Americans. (1990) (92)
Incidence of NIDDM and Impaired Glucose Tolerance in Hypertensive Subjects: The San Antonio Heart Study (1993) (92)
Obesity in Mexican American subgroups: findings from the San Antonio Heart Study. (1991) (92)
Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study. (2002) (91)
Relationship of sex hormone binding globulin to overall adiposity and body fat distribution in a biethnic population. (1989) (91)
Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets. (2002) (91)
Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial. (2008) (90)
Molecular basis of a linkage peak: exome sequencing and family-based analysis identify a rare genetic variant in the ADIPOQ gene in the IRAS Family Study. (2010) (90)
Hyperglycemia as a cardiovascular risk factor. (2003) (89)
Insulin sensitivity and the risk of incident hypertension: insights from the Insulin Resistance Atherosclerosis Study. (2003) (89)
Leptin concentrations in women in the San Antonio Heart Study: effect of menopausal status and postmenopausal hormone replacement therapy. (1997) (89)
Insulin Resistance, β-Cell Dysfunction, and Conversion to Type 2 Diabetes in a Multiethnic Population (2009) (88)
Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance. (2002) (88)
Low insulin sensitivity is associated with clustering of cardiovascular disease risk factors. (1997) (87)
Genetic and Environmental Determinants of Type II Diabetes in Mexican Americans: Is There a “Descending Limb” to the Modernization/Diabetes Relationship? (1991) (87)
Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study. (2008) (86)
Genetics of atherosclerosis risk factors in Mexican Americans. (2009) (86)
C‐reactive protein is more strongly related to post‐glucose load glucose than to fasting glucose in non‐diabetic subjects; the Insulin Resistance Atherosclerosis Study (2002) (86)
Linkage of the metabolic syndrome to 1q23-q31 in Hispanic families: the Insulin Resistance Atherosclerosis Study Family Study. (2004) (86)
Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS). (1999) (85)
Proinsulin and insulin concentrations in relation to carotid wall thickness: Insulin Resistance Atherosclerosis Study. (1998) (84)
Insulin Clearance and the Incidence of Type 2 Diabetes in Hispanics and African Americans (2013) (84)
Dyslipidemia in type II Diabetes: Implications for Therapeutic Intervention (1991) (83)
Coffee consumption, diet, and lipids. (1985) (83)
Increased prevalence of clinical gallbladder disease in subjects with non-insulin-dependent diabetes mellitus. (1990) (82)
Insulin resistance, beta-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: the Insulin Resistance Atherosclerosis Study. (2010) (82)
Sex Hormones and DHEA-SO4 in Relation to Ischemic Heart Disease Mortality in Diabetic subjects: The Wisconsin Epidemiologic Study of Diabetic Retinopathy (1996) (82)
The relation between serum insulin levels and 8-year changes in lipid, lipoprotein, and blood pressure levels. (1992) (81)
Sex Difference in Lifestyle Factors Predictive of Diabetes in Mexican-Americans (1995) (81)
Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. (1998) (81)
Decreased prevalence of hypertension in Mexican-Americans. (1990) (81)
Down-regulation of the low-density lipoprotein receptor by dietary cholesterol. (1984) (81)
Hyperdynamic circulation and the insulin resistance syndrome ("syndrome X"). (1992) (80)
Does obesity explain excess prevalence of diabetes among Mexican Americans? Results of the San Antonio heart study (1983) (80)
Increased risk of non‐insulin-dependent diabetes mellitus in elderly hypertensive subjects (1994) (80)
Cardiovascular risk factors in non-insulin-dependent diabetic subjects with microalbuminuria. (1993) (79)
Coronary risk factors and clinical gallbladder disease: an approach to the prevention of gallstones? (1987) (78)
Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study (1997) (78)
Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects. (2000) (78)
Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study (2013) (78)
Lack of change of lipoprotein (a) concentration with improved glycemic control in subjects with type II diabetes. (1992) (78)
Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: the insulin resistance atherosclerosis study (IRAS) family study. (2004) (77)
Cigarette smoking, environmental tobacco smoke exposure and insulin sensitivity: the Insulin Resistance Atherosclerosis Study. (1999) (77)
The Scandinavian Simvastatin Survival Study (4S) Subgroup Analysis of Diabetic Subjects: Implications for the Prevention of Coronary Heart Disease (1997) (76)
Predicting future cardiovascular disease: do we need the oral glucose tolerance test? (2002) (76)
Using metabolic syndrome traits for efficient detection of impaired glucose tolerance. (2004) (75)
Association of PNPLA3 with non‐alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study (2011) (75)
Obesity and the metabolic syndrome: the San Antonio Heart Study (2000) (75)
Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance (1996) (75)
LDL size and subclass pattern in a biethnic population. (1993) (74)
The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed Type II diabetes: the Insulin Resistance Atherosclerosis Study (1999) (74)
Greater influence of central distribution of adipose tissue on incidence of non-insulin-dependent diabetes in women than men. (1991) (74)
Effect of diabetes on lipoprotein size. (1995) (74)
Relationship of low-density lipoprotein particle size and measures of adiposity (1999) (74)
Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects. (1994) (73)
Serum leptin in obesity is related to gender and body fat topography but does not predict successful weight loss. (1997) (72)
Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors. (2008) (72)
Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and treatment patterns. (2006) (72)
Ethnic differences in health knowledge and behaviors related to the prevention and treatment of coronary heart disease. The San Antonio Heart Study. (1983) (72)
Genetic analysis of adiponectin and obesity in Hispanic families: the IRAS Family Study (2005) (71)
Elevated Carotid Artery Intima-Media Thickness Levels in Individuals Who Subsequently Develop Type 2 Diabetes (2003) (71)
Insulin sensitivity is not an independent determinant of plasma plasminogen activator inhibitor-1 activity. (1994) (71)
Lipoprotein(a) and Diabetes: An update (1993) (70)
Associations between the intake of caffeinated and decaffeinated coffee and measures of insulin sensitivity and beta cell function (2011) (70)
Insulin and 2-hour glucose levels are inversely related to Lp(a) concentrations controlled for LPA genotype. (1998) (70)
Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study (2014) (70)
Impaired fasting glucose and impaired glucose tolerance have distinct lipoprotein and apolipoprotein changes: the insulin resistance atherosclerosis study. (2013) (69)
A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of Type 2 diabetic patients in North America and Europe (2006) (69)
Relationship of insulin clearance and secretion to insulin sensitivity in non‐diabetic Mexican Americans (1992) (68)
Central adiposity and gallbladder disease in Mexican Americans. (1989) (68)
Lipoprotein(a) concentrations in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study. (1992) (68)
Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE) (2012) (68)
Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy. (2011) (67)
Hyperlipidemia: diagnostic and therapeutic perspectives. (2000) (67)
Performance Characteristics of the New Definition of Diabetes (2009) (67)
Identification of quantitative trait loci for glucose homeostasis: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. (2004) (67)
Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors? (2003) (66)
LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study. (1999) (65)
Increased insulin concentrations in nondiabetic offspring of diabetic parents. (1988) (65)
Genetic and environmental correlations among hormone levels and measures of body fat accumulation and topography. (1996) (65)
Increased lipoprotein(a) concentrations in chronic renal failure. (1992) (65)
A saturated fat/cholesterol avoidance scale: sex and ethnic differences in a biethnic population. (1988) (64)
Preliminary report: kinetic studies on the modulation of high-density lipoprotein, apolipoprotein, and subfraction metabolism by sex steroids in a postmenopausal woman. (1984) (64)
Are risk factors for conversion to NIDDM similar in high and low risk populations? (1997) (64)
Overweight and mortality in Mexican Americans. (1990) (64)
Effects of NIDDM on Lipoprotein(a) Concentration and Apolipoprotein(a) Size (1994) (63)
Insulin sensitivity and hypertension. (1990) (63)
Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects (1995) (63)
Evidence of bimodality of two hour plasma glucose concentrations in Mexican Americans: results from the San Antonio Heart study. (1985) (63)
Eight-year incidence of hypertension in Mexican-Americans and non-Hispanic whites. The San Antonio Heart Study. (1992) (62)
Clinical relevance of the oxidative stress concept. (2000) (62)
Prevalence of Hypertension in Hispanic and non-Hispanic White Populations (2002) (62)
Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico. (2001) (61)
Prediction of Type 2 Diabetes Using Alternate Anthropometric Measures in a Multi-Ethnic Cohort (2009) (61)
Association of 25-hydroxyvitamin D with blood pressure in predominantly 25-hydroxyvitamin D deficient Hispanic and African Americans. (2009) (60)
Proinsulin-to-C-peptide ratio versus proinsulin-to-insulin ratio in the prediction of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) (2011) (60)
Calcium and phosphate concentrations and future development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study (2014) (59)
Greater Effect of Glycemia on Incidence of Hypertension in Women Than in Men (1992) (59)
Genome-wide association study of vitamin D concentrations in Hispanic Americans: The IRAS Family Study (2010) (59)
Is leptin concentration associated with the insulin resistance syndrome in nondiabetic men? (1999) (58)
Insulin and blood pressure: fact or fantasy? (1993) (58)
Hypertension, Insulin, and Proinsulin in Participants With Impaired Glucose Tolerance (2002) (58)
Is Prehypertension a Risk Factor for the Development of Type 2 Diabetes? (2009) (57)
Quantitative trait loci for abdominal fat and BMI in Hispanic-Americans and African-Americans: the IRAS Family Study (2005) (56)
High blood pressure and insulin resistance: influence of ethnic background (1991) (56)
Serum leptin in relation to resting energy expenditure and fuel metabolism in obese subjects (1997) (56)
Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels. The Insulin Resistance Atherosclerosis Study. (1999) (55)
Secondary prevention of coronary heart disease: the role of fibric acids. (2000) (55)
Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes. (1998) (55)
Relationship of LDL size to insulin sensitivity in normoglycemic men. (1997) (55)
Prevalence, detection, and control of hypertension in a biethnic community. The San Antonio Heart Study. (1985) (54)
Which Obesity Index Best Explains Prevalence Differences in Type 2 Diabetes Mellitus? (2007) (54)
Apolipoprotein E polymorphism and LDL size in a biethnic population. (1996) (54)
Diabetes, Abdominal Adiposity, and Atherogenic Dyslipoproteinemia in Women Compared With Men (2008) (53)
A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects (1995) (53)
The prevalence of the metabolic syndrome did not increase in Mexico City between 1990-1992 and 1997-1999 despite more central obesity. (2005) (53)
Analysis of FTO gene variants with obesity and glucose homeostasis measures in the multiethnic Insulin Resistance Atherosclerosis Study cohort (2011) (53)
Exenatide and sitagliptin are not associated with increased risk of acute renal failure: a retrospective claims analysis (2012) (51)
Association Between NIDDM, RH Blood Group, and Haptoglobin Phenotype: Results from the San Antonio Heart Study (1986) (51)
Impaired Glucose Tolerance, Insulin Resistance and Cardiovascular Disease (1997) (51)
Metabolic Factors, Adipose Tissue, and Plasminogen Activator Inhibitor-1 Levels in Type 2 Diabetes: Findings From the Look AHEAD Study (2011) (51)
Differential white cell count and incident type 2 diabetes: the Insulin Resistance Atherosclerosis Study (2013) (51)
Insulin sensitivity and intake of vitamins E and C in African American, Hispanic, and non-Hispanic white men and women: the Insulin Resistance and Atherosclerosis Study (IRAS). (1997) (51)
Association of TCF7L2 gene polymorphisms with reduced acute insulin response in Hispanic Americans. (2008) (50)
Does Glycemic Control of Type II Diabetes Suffice to Control Diabetic Dyslipidemia?: A Community Perspective (1992) (50)
Genome‐wide Association Study and Follow‐up Analysis of Adiposity Traits in Hispanic Americans: The IRAS Family Study (2009) (50)
A new concept of impaired glucose tolerance. Relation to cardiovascular risk. (1985) (50)
Low levels of sex hormone-binding globulin and testosterone are associated with smaller, denser low density lipoprotein in normoglycemic men. (1996) (50)
Lifestyle intervention and/or statins for the reduction of C-reactive protein in type 2 diabetes: From the Look AHEAD Study (2013) (49)
Lipid and lipoprotein factors associated with variation in Lp(a) density. (1995) (48)
Predicting Diabetes: Moving Beyond Impaired Glucose Tolerance (1993) (48)
Evidence of Interaction Between PPARG2 and HNF4A Contributing to Variation in Insulin Sensitivity in Mexican Americans (2008) (48)
Serum leptin and short-term regulation of eating in obese women. (1997) (48)
The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease. (2008) (48)
A genome-wide association scan for acute insulin response to glucose in Hispanic-Americans: the Insulin Resistance Atherosclerosis Family Study (IRAS FS) (2009) (47)
Trp64Arg Polymorphism of theβ 3-Adrenergic Receptor Gene in Pregnancy: Association with Mild Gestational Diabetes Mellitus (1999) (47)
Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance (2014) (46)
Carotid Intima-Media Thickness in Confirmed Prehypertensive Subjects: Predictors and Progression (2007) (46)
Increase in circulating levels of IGF‐1 and IGF‐1/IGFBP‐3 molar ratio over a decade is associated with colorectal adenomatous polyps (2012) (45)
Is there an ethnic difference in the effect of risk factors for diabetic retinopathy? (1993) (45)
Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial (2012) (45)
Prevalence of Hypertension in Mexico City and San Antonio, Texas (1994) (44)
Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program. (2005) (44)
Role of fibrates in the management of hypertriglyceridemia. (1999) (43)
Site-specific progression of carotid artery intimal-medial thickness. (2003) (42)
Relationship of Insulin Sensitivity, Insulin Secretion, and Adiposity With Insulin Clearance in a Multiethnic Population (2012) (42)
Functional impairment in Mexican Americans and non-Hispanic whites with diabetes. (1990) (42)
Leptin concentrations do not predict weight gain: The Mexico City Diabetes Study (1998) (42)
Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin Over 4 Years Despite Greater Weight Gain (2009) (42)
Employment status and women's protection against coronary heart disease. Findings from the San Antonio Heart Study. (1986) (42)
Polymorphisms near SOCS3 are associated with obesity and glucose homeostasis traits in Hispanic Americans from the Insulin Resistance Atherosclerosis Family Study (2009) (42)
Comparison of rosuvastatin versus atorvastatin in Hispanic-Americans with hypercholesterolemia (from the STARSHIP trial). (2006) (41)
The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart Study. (2007) (41)
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. (2005) (40)
Glibenclamide, but Not Acarbose, Increases Leptin Concentrations Parallel to Changes in Insulin in Subjects With NIDDM (1997) (40)
Insulin, health behaviors, and lipid metabolism. (1993) (40)
Genetic mapping of disposition index and acute insulin response loci on chromosome 11q. The Insulin Resistance Atherosclerosis Study (IRAS) Family Study. (2006) (40)
Epidemiology of hypertension and insulin resistance syndrome. (1997) (40)
Metabolic and Antihypertensive Effects of Combined Angiotensin Receptor Blocker and Diuretic Therapy in Prediabetic Hypertensive Patients With the Cardiometabolic Syndrome (2008) (40)
Insulin resistance and excess risk of diabetes in Mexican-Americans: the San Antonio Heart Study. (2012) (39)
Level of control of hypertension in Mexican Americans and non-Hispanic whites. (1993) (39)
Novel Protein Glycan–Derived Markers of Systemic Inflammation and C-Reactive Protein in Relation to Glycemia, Insulin Resistance, and Insulin Secretion (2016) (38)
Determining the most appropriate components for a composite clinical trial outcome. (2008) (38)
Abdominal obesity, insulin resistance, and cardiovascular risk in pre-diabetes and type 2 diabetes (2006) (38)
Ultrasonographically assessed maximum carotid artery wall thickness in Mexico City residents and Mexican Americans living in San Antonio, Texas. Association with diabetes and cardiovascular risk factors. (1996) (38)
Insulin Sensitivity and Insulin Clearance are Heritable and Have Strong Genetic Correlation in Mexican Americans (2013) (37)
Visceral fat and prevalence of hypertension among African Americans and Hispanic Americans: findings from the IRAS family study. (2008) (37)
Dietary intake and the prevalence of gallbladder disease in Mexican Americans. (1989) (37)
Metabolic syndrome – a new risk factor of coronary heart disease? (2003) (37)
Macrovascular Complications in Mexican Americans With Type II Diabetes (1991) (37)
Adiponectin and the mediation of HDL-cholesterol change with improved lifestyle: the Look AHEAD Study[S] (2012) (37)
Excess androgenicity only partially explains the relationship between obesity and bone density in premenopausal women. (1992) (36)
Evidence for a Major Gene Affecting Postchallenge Insulin Levels in Mexican-Americans (1995) (36)
Public health significance of upper body adiposity for non-insulin dependent diabetes mellitus in Mexican Americans. (1992) (36)
Do interventions to reduce coronary heart disease reduce the incidence of type 2 diabetes? A possible role for inflammatory factors. (2001) (36)
Trp64Arg polymorphism of the beta3-adrenergic receptor gene in pregnancy: association with mild gestational diabetes mellitus. (1999) (36)
Inflammation and cardiovascular disease in patients with diabetes: lessons from the Diabetes Control and Complications Trial. (2005) (36)
Relationship of Traditional and Nontraditional Cardiovascular Risk Factors to Coronary Artery Calcium in Type 2 Diabetes (2007) (36)
Is there a sex difference in the association of plasma insulin level and insulin sensitivity with serum lipids and lipoproteins? (1994) (35)
Effects of Cigarette Smoking , Diabetes , High Cholesterol , and Hypertension on All-Cause Mortality and Cardiovascular Disease Mortality in Mexican Americans (2005) (35)
Metabolic Syndrome, New Onset Diabetes, and New End points in Cardiovascular Trials (2006) (35)
Insulin secretion and resistance in nondiabetic Mexican Americans and non-Hispanic whites with a parental history of diabetes. (1996) (35)
Association of Abdominal Adiposity With Diabetes and Cardiovascular Disease in Latin America (2009) (35)
Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial. (2015) (35)
Hemoglobin A 1 c between 5 . 7 and 6 . 4 % as a marker for identifying prediabetes , insulin sensitivity and secretion , and cardiovascular risk factors : The Insulin Resistance Atherosclerosis Study ( IRAS ) (2010) (35)
Fasting and OGTT-derived measures of insulin resistance as compared with the euglycemic-hyperinsulinemic clamp in nondiabetic Finnish offspring of type 2 diabetic individuals. (2015) (34)
Risk factors for non-insulin-dependent diabetes mellitus (1995) (34)
Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial. (2013) (34)
Genetic Modulation of Lipid Profiles following Lifestyle Modification or Metformin Treatment: The Diabetes Prevention Program (2012) (33)
Serum leptin in subjects with impaired glucose tolerance in relation to insulin sensitivity and first-phase insulin response (1997) (33)
Quantitative genetics of serum sex hormone-binding globulin levels in participants in the San Antonio Family Heart Study. (1997) (33)
Do high proinsulin and C-peptide levels play a role in autonomic nervous dysfunction?: Power spectral analysis in patients with non-insulin-dependent diabetes and nondiabetic subjects. (1997) (33)
Risk of type 2 diabetes among individuals with high and low glomerular filtration rates (2009) (32)
Cardiovascular risk factors and the prediabetic syndrome. (1996) (32)
The prediabetic problem: development of non-insulin-dependent diabetes mellitus and related abnormalities. (1997) (32)
Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: results from NAVIGATOR. (2014) (32)
Increased testosterone in type I diabetic subjects with severe retinopathy. (1990) (32)
The Mexico City Diabetes Study: a population-based approach to the study of genetic and environmental interactions in the pathogenesis of obesity and diabetes. (2009) (31)
Leptin concentrations are associated with higher proinsulin and insulin concentrations but a lower proinsulin/insulin ratio in non-diabetic subjects (1998) (31)
Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis Study. (2000) (31)
Serum leptin, food intake and preferences for sugar and fat in obese women (1998) (30)
High prevalence of cholelithiasis in a low income Mexican population: an ultrasonographic survey. (1997) (30)
Candidate loci for insulin sensitivity and disposition index from a genome-wide association analysis of Hispanic participants in the Insulin Resistance Atherosclerosis (IRAS) Family Study (2010) (30)
The association between leptin and left ventricular hypertrophy: a population-based cross-sectional study. (2003) (30)
Associations of coffee consumption with markers of liver injury in the insulin resistance atherosclerosis study (2015) (29)
Prevalence of Hypertension in a Mexican Population According to the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (1999) (29)
Five-Year Change in Visceral Adipose Tissue Quantity in a Minority Cohort: The Insulin Resistance Atherosclerosis Study (IRAS) Family Study (2009) (29)
Long-Term Titrated-Dose α-Glucosidase Inhibition in Non-Insulin-Requiring Hispanic NIDDM Patients (1998) (29)
Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes. (1999) (29)
Adiponectin and the Incidence of Type 2 Diabetes in Hispanics and African Americans (2011) (29)
Relation of statin nonadherence and treatment intensification. (2012) (29)
Association of proopiomelanocortin gene polymorphisms with obesity in the IRAS family study. (2005) (29)
β-Cell Dysfunction in Subjects With Impaired Glucose Tolerance and Early Type 2 Diabetes (2008) (29)
Lack of association between sex hormones and Lp(a) concentrations in American and Finnish men. (1994) (28)
Clustering of Cardiovascular Risk Factors (1998) (28)
Hypertriglyceridemia: management of atherogenic dyslipidemia. (2006) (28)
INSIG2 SNPs Associated With Obesity and Glucose Homeostasis Traits in Hispanics: The IRAS Family Study (2009) (27)
Pleiotropy and Heterogeneity in the Expression of Atherogenic Lipoproteins: The IRAS Family Study (2003) (27)
Height, ethnicity, and the incidence of diabetes: the San Antonio Heart Study. (2009) (27)
Predictors of Incident Heart Failure Hospitalizations Among Patients With Impaired Glucose Tolerance: Insight From the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research Study (2013) (27)
Differential impact of insulin and obesity on cardiovascular risk factors in non-diabetic subjects. (1996) (27)
Leptin concentrations and their relation to body fat distribution and weight loss--a prospective study in individuals with impaired glucose tolerance. DPS-study group. (1999) (26)
Performance of semiquantitative food frequency questionnaires in international comparisons. Mexico City versus San Antonio, Texas. (1993) (26)
The Metabolic Syndrome: Risk Factors and Management (2006) (26)
Midcourse correction to a clinical trial when the event rate is underestimated: the Look AHEAD (Action for Health in Diabetes) Study (2012) (26)
Diabetes and coronary heart disease risk in Mexican Americans. (1992) (25)
Hyperinsulinemia as a possible etiology for the high prevalence of non insulin dependent diabetes in Mexican Americans. (1987) (25)
Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with Type 2 diabetes. (2002) (25)
Pulse pressure, prehypertension, and mortality: the San Antonio heart study. (2009) (25)
Diabetes is more lethal in Mexicans and Mexican-Americans compared to Non-Hispanic whites. (2011) (25)
International Day for the Evaluation of Abdominal obesity: rationale and design of a primary care study on the prevalence of abdominal obesity and associated factors in 63 countries (2006) (25)
Diabetes and the metabolic syndrome--when is it best to intervene to prevent? (2006) (24)
Plasma leptin in non‐diabetic Asian Indians: association with abdominal adiposity (1997) (24)
Genetic relationship between measures of HDL phenotypes and insulin concentrations. (1997) (24)
Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD (2015) (24)
Retarded chylomicron apolipoprotein-B catabolism in Type 2 (non-insulin-dependent) diabetic subjects with lipaemia (1984) (23)
Can reducing peaks prevent type 2 diabetes: implication from recent diabetes prevention trials. (2002) (23)
Quantitative genetics of dehydroepiandrosterone sulfate and its relation to possible cardiovascular disease risk factors in Mexican Americans. (1996) (23)
A genome scan for fasting insulin and fasting glucose identifies a quantitative trait locus on chromosome 17p: the insulin resistance atherosclerosis study (IRAS) family study. (2005) (23)
The association of alanine aminotransferase within the normal and mildly elevated range with lipoproteins and apolipoproteins: the Insulin Resistance Atherosclerosis Study (2013) (23)
A comparison of three methods for assessing Amerindian admixture in Mexican Americans. (1993) (23)
Association Analysis of the Plasminogen Activator Inhibitor-1 4G/5G Polymorphism in Hispanics and African Americans: The IRAS Family Study (2004) (22)
Dietary intakes of essential nutrients among Mexican-Americans and Anglo-Americans: the San Antonio Heart Study. (1985) (22)
Predictors of obesity in Mexican Americans. (1991) (22)
Usual consumption of plant foods containing phytoestrogens and sex hormone levels in postmenopausal women in Wisconsin. (1998) (22)
Haplotypes in the lipoprotein lipase gene influence fasting insulin and discovery of a new risk haplotype. (2007) (22)
NT‐proBNP by Itself Predicts Death and Cardiovascular Events in High‐Risk Patients With Type 2 Diabetes Mellitus (2020) (22)
Microalbuminuria as a predictor of myocardial infarction in a Mexican population: the Mexico City Diabetes Study. (2005) (22)
Insulin sensitivity, body fat distribution, and family diabetes history: the IRAS Family Study. (2004) (22)
AUDIT study. Evidence of global undertreatment of dyslipidaemia in patients with type 2 diabetes mellitus (2006) (22)
Specific insulin and proinsulin concentrations in nondiabetic South Indians. (1998) (21)
Relationship of plasma insulin concentration and insulin sensitivity to blood pressure. Is it modified by obesity? (1996) (21)
Fish consumption, insulin sensitivity and beta-cell function in the Insulin Resistance Atherosclerosis Study (IRAS). (2013) (21)
Insulin Sensitivity and Lp(a) Concentrations in Normoglycemic Men (1995) (21)
Progress and Controversies: Treating Obesity and Insulin Resistance in the Context of Hypertension (2009) (20)
Rationale for new American Diabetes Association Guidelines: are national cholesterol education program goals adequate for the patient with diabetes mellitus? (2005) (20)
Marine omega-3 fatty acid intake: associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study. (2009) (20)
Marine ω-3 Fatty Acid Intake (2009) (20)
A Metabolically Healthy Obese Phenotype in Hispanic Participants in the IRAS Family Study (2013) (20)
Relation of low glomerular filtration rate to metabolic disorders in individuals without diabetes and with normoalbuminuria. (2008) (20)
Impaired glucose tolerance – is it relevant for cardiovascular disease? (1997) (20)
Glucose and insulin levels during diuretic therapy in hypertensive men. (1994) (20)
Changes in Albumin Excretion in the Diabetes Prevention Program (2009) (19)
Glycated hemoglobin levels are mostly dependent on nonglycemic parameters in 9398 Finnish men without diabetes. (2015) (19)
Genetic mapping of a 17q chromosomal region linked to obesity phenotypes in the IRAS family study (2006) (19)
Impact of differences in glucose tolerance on the prevalence of a negative insulinogenic index. (2013) (19)
Differential impact of obesity in related populations. (1995) (19)
Apolipoprotein B (apo B) signal peptide length polymorphisms are associated with apo B, low density lipoprotein cholesterol, and glucose levels in Mexican Americans. (1996) (18)
High prevalence of angina pectoris in Mexican-American men. A population with reduced risk of myocardial infarction. (1991) (18)
Insulin secretion based on the late oral glucose tolerance test period and incident diabetes: the San Antonio Heart Study (2012) (18)
Progress in Population Analyses of the Insulin Resistance Syndrome (1997) (18)
Sex hormones and the incidence of severe retinopathy in male subjects with type I diabetes. (1993) (18)
Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin over Four-Years in Spite of Greater Weight Gain: Observations from ADOPT (A Diabetes Outcome Progression Trial) (2009) (17)
Undiagnosed hypercholesterolemia: a serious health challenge. The Mexico City Diabetes Study. (1996) (17)
Seven-year incidence and progression of obesity. Characterization of body fat pattern evolution in low-income Mexico City urban population. (2003) (17)
The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS) (2012) (17)
Diabetes abolishes the gender gap in coronary heart disease. (2003) (17)
Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial (2017) (17)
Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma (2015) (16)
Statin therapy for the treatment of diabetic dyslipidemia (2003) (16)
Components of metabolic syndrome and 5‐year change in insulin clearance – the Insulin Resistance Atherosclerosis Study (2013) (16)
Measurement characteristics of the ankle–brachial index: results from the Action for Health in Diabetes study (2008) (16)
Do increased proinsulin concentrations explain the excess risk of coronary heart disease in diabetic and prediabetic subjects? (2002) (16)
Insulin resistant phenotype is associated with high serum leptin levels in offspring of patients with non-insulin-dependent diabetes mellitus. (1998) (15)
Hyperproinsulinemia is not a characteristic feature in the offspring of patients with different phenotypes of type II diabetes. (2000) (15)
Glucose-tolerance testing in acute myocardial infarction (2002) (15)
Predictors of Incident Heart Failure Hospitalizations Among Patients With Impaired Glucose ToleranceClinical Perspective (2013) (15)
Pioglitazone-mediated changes in lipoprotein particle composition are predicted by changes in adiponectin level in type 2 diabetes. (2012) (15)
Association between ADIPOQ SNPs with plasma adiponectin and glucose homeostasis and adiposity phenotypes in the IRAS Family Study. (2012) (15)
Prevalence and detection of hypertension in Mexico. (1994) (14)
of the National Heart , Lung , and Blood Institute – National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus (2005) (14)
The relationship of insulin sensitivity and metabolic clearance of insulin to adiposity and sex hormone binding globulin. (1990) (14)
Metabolism of chylomicrons in subjects with dysbetalipoproteinaemia (type III hyperlipoproteinaemia) (1989) (13)
Metabolic predictors of hypertension. (1999) (13)
Plasma oxidizability in Mexican-Americans and non-Hispanic whites. (1996) (13)
Patients with type 2 diabetes: the case for primary prevention. (1999) (13)
Lower hypertension risk in Mexico City than in San Antonio. (2005) (13)
Evaluation of two insulin assays in insulin resistance syndrome (syndrome X). (1994) (13)
Prospective relationships between body weight and physical activity: an observational analysis from the NAVIGATOR study (2015) (13)
Dual renin-angiotensin system blockade and kidney disease. (2009) (13)
New strategies for the treatment of diabetic dyslipidemia. (2002) (13)
Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trial (2018) (12)
The insulin resistance syndrome in Mexico. Prevalence and clinical characteristics: a population based study. (1995) (12)
The association between leptin and left ventricular hypertrophy: a population-based cross-sectional study (2003) (12)
The importance of postprandial hyperglycaemia in development of cardiovascular disease in people with diabetes: point. (2001) (12)
Prospective assessment of metabolic control in diabetes mellitus: the complications question. (1988) (11)
Longitudinal decline of β-cell function: comparison of a direct method vs a fasting surrogate measure: the Insulin Resistance Atherosclerosis Study. (2013) (11)
Lp(a) is not Related to Retinopathy in Diabetic Subjects (1995) (11)
Genetic correlations between lipoprotein phenotypes and indicators of sex hormone levels in Mexican Americans. (1996) (11)
Association of Directly Measured Plasma Free 25(OH)D With Insulin Sensitivity and Secretion: The IRAS Family Study (2017) (11)
Variant in the 3′ Region of the IκBα Gene Associated With Insulin Resistance in Hispanic Americans: The IRAS Family Study (2010) (11)
35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
Moderate-to-Severe Diabetic Retinopathy Is More Prevalent in Mexico City Than in San Antonio, Texas (1997) (11)
NMR identifies atherogenic lipoprotein abnormalities in early diabetic nephropathy that are unrecognized by conventional analysis. (2010) (11)
Insulin Resistance and Atherosclerosis: An overview (1996) (11)
Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials. (2010) (10)
Comparative Effectiveness of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study (2012) (10)
Cardiologists should care about glucose: most people with CV disease or risk factors have diabetes or significant glycaemic abnormalities. Results of screening over 39,000 subjects for NAVIGATOR (2004) (10)
Plasma leptin is not associated with insulin resistance and proinsulin in non‐diabetic South Asian Indians (1998) (10)
Prevalence of Metabolic Syndrome and Coronary Heart Disease Using NCEP and WHO Criteria (2002) (10)
Metabolic syndrome and diabetes mellitus. (2004) (10)
Estimating the Contributions of Rare and Common Genetic Variations and Clinical Measures to a Model Trait: Adiponectin (2013) (10)
Insights from apoB: from better diagnosis & therapy to the Medusa Hypothesis. (2004) (10)
Individual serum saturated fatty acids and markers of chronic subclinical inflammation: the Insulin Resistance Atherosclerosis Study[S] (2017) (10)
Chronic obstructive pulmonary disease and cardiovascular risk: insights from the NAVIGATOR trial. (2014) (10)
[Blood lipid levels and atherogenic risk in an open urban population]. (1993) (9)
Re: "(Mis)use of factor analysis in the study of insulin resistance syndrome". (2005) (9)
Chylomicron and very low-density lipoprotein apolipoprotein B metabolism: mechanism of the response to stanozolol in a patient with severe hypertriglyceridemia. (1984) (9)
Effect of valsartan on kidney outcomes in people with impaired glucose tolerance (2017) (9)
Egg consumption and insulin metabolism in the Insulin Resistance Atherosclerosis Study (IRAS) (2013) (9)
Predicting Impaired Glucose Tolerance (IGT) among Individuals with a Non-Diabetic Fasting Glucose Value: The San Antonio Heart Study (2002) (9)
Sample exchange to compare insulin measurements between the San Antonio Heart Study and the Framingham Offspring Study. (2001) (9)
Fiber intake and plasminogen activator inhibitor-1 in type 2 diabetes: Look AHEAD (Action for Health in Diabetes) trial findings at baseline and year 1. (2014) (9)
Predicting risk reduction of coronary disease in patients who are glucose intolerant: a comparison of treatment with fenofibrate and other lipid-modifying agents. (2000) (8)
Metabolic syndrome, diabetes and coronary heart disease. (2002) (8)
Impaired Glucose Tolerance and Obesity as Effect Modifiers of Ethnic Disparities of the Progression to Diabetes (2012) (8)
Hypertension in the San Antonio Heart Study and the Mexico City Diabetes Study: clinical and metabolic correlates. (1996) (8)
Do anthropometric differences between Mexican Americans and non-Hispanic whites explain ethnic differences in metabolic variables? (2009) (8)
Cross-Sectional and Longitudinal Changes of Glucose Effectiveness in Relation to Glucose Tolerance (2011) (7)
Compositional and metabolic heterogeneity of α2- and β-very-low-density lipoproteins in subjects with broad beta disease and endogenous hypertriglyceridemia (1985) (7)
Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: influence of apolipoprotein E-3/E-2 pattern. (1992) (7)
Do we need the oral glucose tolerance test to identify future cases of type 2 diabetes? (2003) (7)
Impaired Glucose Tolerance and Obesity as Effect Modi fi ers of Ethnic Disparities of the Progression to Diabetes The San Antonio Heart Study (2012) (7)
A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk. (2013) (7)
Pioglitazone Versus Glimepiride on Coronary Artery Calcium Progression in Patients With Type 2 Diabetes Mellitus: A Secondary End Point of the CHICAGO Study (2010) (7)
Prediabetes and the risk of diabetes (2012) (7)
Rosiglitazone Associated Fractures in Type 2 Diabetes: An Analysis From ADOPT (2008) (7)
Body Size and Shape Changes and the Risk of Diabetes in the Diabetes Prevention Program (DPP) Received for publication 3 January 2007 and accepted in revised form 7 March 2007. The Diabetes Prevention Program Research Group (2007) (7)
Predictors of Stroke in Patients With Impaired Glucose Tolerance: Results From the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research Trial (2013) (7)
Abstract 14666: Intensive Lifestyle Intervention Further Reduces High-Sensitivity C-Reactive Protein in Statin Users, Findings From the Look Ahead (Action for Health in Diabetes) Study (2010) (6)
Defining the metabolic syndrome: Resolving unresolved issues? (2007) (6)
Cosegregation of albuminuria and blood pressure: the Insulin Resistance Atherosclerosis (IRAS) family study. (2005) (6)
Updated risk factors should be used to predict development of diabetes. (2017) (6)
Management of Dyslipidemia in Adults With Diabetes (1998) (5)
Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Snijder et al. (2003) (5)
Subtle hyperproinsulinaemia characterises the defective insulin secretory capacity in offspring of glutamic acid decarboxylase antibody-positive patients with latent autoimmune diabetes mellitus in adults. (2005) (5)
[Prevalence of diabetes and glucose intolerance in a urban population at a low economic level]. (1992) (5)
Diabetes and hypertension: the scope of the problem. (1996) (5)
The Editor's Roundtable: the metabolic syndrome. (2007) (5)
Marine Omega-3 Fatty Acid Intake: Associations with Cardiometabolic Risk and Response to Weight Loss Intervention in The Look AHEAD Study Running title: Marine omega-3 fatty acid intake in Look AHEAD (2009) (5)
LDL size and subclass pattern in Mexico City residents and San Antonio Mexican Americans. (1995) (5)
Proinsulin in pregnant women with normal glucose tolerance or mild gestational diabetes mellitus. (2009) (5)
The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience (2022) (5)
Association of SSTR2 Polymorphisms and Glucose Homeostasis Phenotypes (2009) (4)
Exploring differences in adiposity in two U.S. Hispanic populations of Mexican origin using social, behavioral, physiologic and genetic markers: the IRAS Family Study. (2012) (4)
Is All Coronary Heart Disease Prevention in Type 2 Diabetes Mellitus Secondary Prevention (2000) (4)
Disproportionately elevated proinsulinemia is observed at modestly elevated glucose levels within the normoglycemic range (2014) (4)
Compositional changes in lipoproteins of subjects with non-insulin-dependent diabetes mellitus. (1991) (4)
Lipids and syndromes of insulin resistance : from molecular biology to clinical medicine (1997) (4)
Carotid artery atherosclerosis in a Mexico City population with high carbohydrate intake. (1995) (4)
1P-0290 Designs of 3 trials comparing rosuvastatin and atorvastatin in African American, South Asian, and Hispanic patients: ARIES, IRIS and STARSHIP trials (2003) (3)
Lp(a) concentrations and phenotypes in children with insulin-dependent diabetes mellitus. (1994) (3)
Issues in management: the role of insulin in cardiovascular outcomes. (1998) (3)
Insulin resistance is independently associated with VAT and upper trunk SAT in controls and HIV infection (2006) (3)
Metabolomic profiling of the Dietary Approaches to Stop Hypertension diet provides novel insights for the nutritional epidemiology of type 2 diabetes mellitus (2021) (3)
Lack of Association Between Insulin Sensitivity and Colorectal Adenoma Risk (2010) (3)
Is there a glycemic threshold? (1997) (3)
The 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) score and diabetes risk in the Diabetes Prevention Program Outcomes Study (DPPOS) (2022) (3)
Myocardial Infarction in Mexican-Americans (2005) (3)
Type 2 diabetes and the metabolic syndrome: National Cholesterol Education Program guidelines and supporting evidence. (2004) (3)
Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndrome. (2005) (3)
Prevalence of gallbladder disease and associated clinical variables in a low income population of Mexico City. (1996) (3)
Title: Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline Short Title: Guidelines for Patients at Metabolic Risk (2008) (2)
Trp 64 Arg Polymorphism of the b 3 -Adrenergic Receptor Gene in Pregnancy: Association with Mild Gestational Diabetes Mellitus (1999) (2)
Do we need the oral glucose tolerance test (2002) (2)
Compositional and metabolic heterogeneity of alpha 2- and beta-very-low-density lipoproteins in subjects with broad beta disease and endogenous hypertriglyceridemia. (1985) (2)
Oxidative stress: introduction. (2000) (2)
Managing dyslipidemia in adults with diabetes. (2003) (2)
Treating Diabetic Dyslipidemia: A Review of Practical Recommendations Based on Clinical Trials (2006) (2)
Unmet needs in controlling metabolic disease. (2007) (2)
Lipoprotein heterogeneity may help to detect individuals with insulin resistance (2015) (2)
Evidence of Interaction Between PPARG2 and HNF4A Contributing to Variation in Insulin Sensitivity in (2008) (1)
Genetic Score Based on 34 Con fi rmed Type 2 Diabetes Loci Is Associated With Diabetes Incidence and Regression to Normoglycemia in the Diabetes Prevention Program (2011) (1)
Abstract 12297: Relations between Baseline Physical Activity by Pedometer Counts and Future Cardiovascular Events in the NAVIGATOR Study (2012) (1)
Insulin Sensitivity Does Not Account for Differences in Type 2 Diabetes Incidence Between San Antonio, Texas and Mexico City, Mexico (2002) (1)
Detection and treatment of hypercholesterolemia in a biethnic community, 1979–1985 (1988) (1)
Metabolic syndrome and diabetes mellitus - Response. (2004) (1)
Abstract 3632: Increases in HDL-C in the CHICAGO Study Explain the Benefits of Pioglitazone in Reducing CIMT Progression in Patients With Type 2 Diabetes (2007) (1)
Excess Mortality among Individuals with Impaired Glucose Tolerance (IGT) Is Limited to Those Who Develop Diabetes: The San Antonio Heart Study (2002) (1)
NT-PROBNP AND HSTNT IMPROVE CARDIOVASCULAR RISK PREDICTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS, CHRONIC KIDNEY OR CARDIOVASCULAR DISEASE OR BOTH (2014) (1)
Abstract 2374: Whole Grain Intake in Relation to Lipids, Apolipoproteins, and Lipoprotein Subclasses in a Multi-ethnic Cohort: The Insulin Resistance Atherosclerosis Study (2007) (1)
Prevalence of Hypertension in Hispanics in San Antonio and Mexico City. (1996) (1)
ADOPT: The effectiveness of metformin versus glyburide in type 2 diabetes (2007) (1)
Greater reductions in C-reactive protein with rosiglitazone than with glyburide or metformin despite greater weight gain (2007) (1)
Poster Discussion Sessions (2009) (1)
Serum leptin levels during food-exposure in obese women (1997) (1)
[Tobacco use in Mexico City]. (1994) (1)
CHD Prevalence in Americans Age 50 Years and Older Using NCEP and WHO Definitions of Metabolic Syndrome (2004) (1)
Catabolism of alpha2-and beta-very low density lipoproteins in normal and hyperlipidemic subjects. (1981) (1)
4.W23.3 Insulin resistance atherosclerosis and CHD (1997) (1)
Abstract 14642: Do Diuretics, Beta-Blockers, and Statins Increase the Risk of Diabetes in Patients with Impaired Glucose Tolerance? Insights from the NAVIGATOR Study (2012) (1)
Abstract 1081: Lifestyle and Metformin Treatment Favorably Influence Lipoprotein Subfraction Distribution in the Diabetes Prevention Program (2009) (1)
Impact off Diabetes on Mortality After the First Myocardial Infarction (2010) (0)
Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma (2015) (0)
2-OR: Impact of N Terminal Pro B-Type Natriuretic Peptide and High Sensitivity Cardiac Troponin on the Prediction of Death and Cardiovascular Events in High-Risk Patients with Type 2 Diabetes (2020) (0)
Abstract 9515: NMR Spectroscopy Uncovers Important Atherogenic Lipoprotein Abnormalities in Nonalcoholic Fatty Liver Disease: The Insulin Resistance Atherosclerosis Study (IRAS). (2011) (0)
Impaired glucose tolerance : is it relevant for cardiovascular disease? : Macrovascular disease in diabetes (1997) (0)
Aggressive lipid lowering with atorvastatin reduces increased risk of cardiovascular events in patients with metabolic syndrome and coronary heart disease (2006) (0)
Studies Comparing Cardiovascular Mortality Between Mexican-Americans and Non-Hispanic Whites Men Women Time Rate * Rate Geographic area period Mortality end point MA NHW MA / NHW MA NHW MA (2005) (0)
Contents, Vol. 46, 1996 (1993) (0)
Diabetes in the West of Scotland Coronary Prevention Study Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart (2003) (0)
Are There People Who Do Not Need to Lose Weight: The Role of Body Fat Distribution and Implications from Diabetes Research (1995) (0)
Risk factors for fatal and non-fatal cardiovascular events in 9306 subjects in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial (2011) (0)
Response from Dr. Diehl, et al. (1988) (0)
Direct Measurement of Nitric Oxide Concentration in CAPD Dialysate (2009) (0)
Abstract 4637: Intra-individual changes in circulating IGF-1 and IGF-1/IGFBP-3 molar ratio are associated with colorectal adenomatous polyps presence (2011) (0)
lin . Proinsulin is increased relative to insulin in subjects with type 2 diabetes in all studies (1998) (0)
Advances in oxidative stress : proceedings of an "expert session" held on the occasion of the annual meeting of the European Association for the study of diabetes, Barcelona, Spain, September 8, 1998 (2000) (0)
Acknowledgement to the Reviewers, Vol. 46, 1996 (1996) (0)
Cholesterol goals established for patients with diabetes and metabolic syndrome. (2002) (0)
Abstract P415: Association of Baseline Physical Activity by Pedometer Counts and Nutritional Behavior on Metabolic Syndrome in the NAVIGATOR Study (2013) (0)
Insulin sensitivity, body fat distribution, and family history of diabetes: The IRAS Family Study (2004) (0)
Leptin Concentrations, Sex Hormones, and Cortisol in Nondiabetic Men—Authors’ Response (1998) (0)
Increased incidence of fractures in women who received rosiglitazone in ADOPT (A Diabetes Outcome Progression Trial) (2007) (0)
Risk Assessment: Metabolic Syndrome and Obesity (2006) (0)
A symposium : clinical significance and management of hypertriglyceridemia (1999) (0)
Tolerance : The Insulin Resistance Atherosclerosis Study Cross-Sectional and Longitudinal Changes of Glucose Effectiveness in Relation to Glucose (2011) (0)
CARDIOVASCULAR DISEASE : The emerging role of the endothelium and implications for treatment (2001) (0)
Abstract 17176: Adiponectin, Metabolic Factors and CRP Changes with a Lifestyle Intervention for Weight Loss in Men and Women with Diabetes: Insights From the Look Ahead (Action for Health in Diabetes) Study (2011) (0)
Reply: To PMID 25499404. (2015) (0)
the BEST trial The effect of diabetes on outcomes of patients with advanced heart failure in (2011) (0)
Abstract 17263: Likelihood of Developing Diabetes and Cardiovascular Disease in Metabolically Obese Normal Weight Individuals (2010) (0)
Americans Association of Plasma Vitamin D Levels with Adiposity in Hispanic and African (2009) (0)
1576-P: Metabolomic Profiling of the Dietary Approaches to Stop Hypertension (DASH) Diet: Novel Insights for the Nutritional Epidemiology of Type 2 Diabetes Mellitus (T2DM) (2019) (0)
Subject Index Vol. 46, 1996 (1996) (0)
Insulinsensitivity and intakeof vitaminsE and C inAfrican American,Hispanic,and non-Hispanic whitemenand women:the InsulinResistance andAtherosclerosis Study (1997) (0)
COMPARISON BETWEEN CENTRAL CLINICAL EVENTS CLASSIFICATION COMMITTEE AND SITE INVESTIGATOR ASSESSMENT OF CLINICAL OUTCOMES: INSIGHTS FROM THE NAVIGATOR TRIAL (2016) (0)
Pearson Correlations Between Systolic and Oiastollc Blood Pressures and Selected Variables Systolic blood pressure Diastolic blood pressure Variable Age BMI Centrality Fasting glucose 2-Hour glucose Fasting insulin 2-Hour insulin (2005) (0)
Changes in bone metabolism biomarkers in the ADOPT study (2008) (0)
Type II Diabetes in Mexican Americans: A Public Health Challenge (2019) (0)
Abstract 1300: Improvement in Glucose Control With Lifestyle Intervention Reduces C-Reactive Protein in Obese Subjects With Type 2 Diabetes: The Look AHEAD Study (2009) (0)
Abstract P382: Visceral Adiposity is a Stronger Correlate of Plasma C-Reactive Protein Levels than Liver Fat in the INSPIRE ME IAA Study. (2012) (0)
Association of non-alcoholic steatothepatitis with components of the metabolic syndrome in 43,509 patients screened for NAVIGATOR (2005) (0)
Errors: Incompetence, ineptitude or failure (2003) (0)
For personal use. Only reproduce with permission from The Lancet Publishing Group. Responding to fear of childbirth (2002) (0)
Insulin resistance and hypertension (1994) (0)
Abstract 15979: Change in Body Mass Index is a Major Determinant of Lifestyle Induced Changes in Lipoprotein Particle Size and Number in the Diabetes Prevention Program (DPP) (2011) (0)
THE RISK OF DIABETES: CAN WE IMPACT CHD THROUGH THE ATP III CHOLESTEROL GUIDELINES? * (2002) (0)
Body Size and Shape Changes and the Risk of Diabetes in the Diabetes Prevention Program (DPP) The Diabetes Prevention Program Research Group (2007) (0)
CLINICAL PERSPECTIVE Hyperlipidemia: Diagnostic and Therapeutic Perspectives (0)
Abstract 15103: Total Adiponectin and Its High Molecular Weight Oligomer Are Associated with The Increase in HDL-Cholesterol Observed with Improved Lifestyle in Obese Diabetic Persons: Findings From the Look Ahead (Action for Health in Diabetes) Study (2011) (0)
State-of-the-Art : Controversies Surrounding the Metabolic Syndrome(New Horizons in the Metabolic Syndrome:-Molecular Mechanisms and Therapies,Plenary Session 4 (PL4) (H),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) (2006) (0)
Determinants of monotherapy failure in ADOPT - (A diabetes outcome progression trial) (2007) (0)
Late‐breaking Trials (2006) (0)
Abstract 14657: Fiber Intake and Plasminogen Activator Inhibitor-1 in Obese Persons With Type 2 Diabetes, Findings From the Look Ahead (Action for Health in Diabetes) Study (2010) (0)
Components of Metabolic Syndrome and the Longitudinal Progression of Insulin Clearance - the Insulin Resistance Atherosclerosis Study (IRAS) (2012) (0)
Diabetes and Cardiovascular Risk: Epidemiologic Aspects (1995) (0)
LDL size and apo E isoform in the San Antonio Heart study (1994) (0)
Insulin resistance, hypertension and type 2 diabetes (2000) (0)
Cohort: The Insulin Resistance Atherosclerosis Study Prediction of Type 2 Diabetes Using Alternate Anthropometric Measures in a Multi-Ethnic (2015) (0)
Greater plasma oxidizability in diabetic subjects than in normal subjects and in subjects with impaired glucose tolerance (1994) (0)
DC111909 556..564 (2012) (0)
Insulin resistance and atherosclerosis. (1996) (0)
Components of Metabolic Syndrome and 5-Year Chance in Insulin Clearance-The Resistance Atherosclerosis Study (IRAS) (2016) (0)
REGIONAL VARIATION IN OUTCOMES IN PATIENTS WITH IMPAIRED FASTING GLUCOSE: INSIGHTS FROM THE NAVIGATOR TRIAL (2016) (0)
M1991 Association of a Variant in the Adiponectin Gene With Liver Enzyme Levels in Hispanic-Americans: The IRAS Family Study (2010) (0)
Die IDEA (International Day for the Evaluation of Abdominal obesity) Studie: Weltweite Prävalenz der abdominellen Fettleibigkeit und ihr Status als kardio-metabolischer Marker (2006) (0)
Evidence of Interaction Between Peroxisome Proliferator-Activated Receptor- γ 2 ( PPARG2 ) and Hepatocyte Nuclear Factor-4 α ( HNF4A ) Contributing to Variation in Insulin Sensitivity in Mexican Americans (2007) (0)
Inflammatory Proteins and 5-year Change in Insulin Clearance – the Insulin Resistance Atherosclerosis Study (IRAS) (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Steven M. Haffner?

Steven M. Haffner is affiliated with the following schools:

Steven M. Haffner's Academic­Influence.com Rankings